Furthermore, cardiac hypertrophy led to a decrease in endogenous levels of D-AKAP1 via downregulation of nuclear-localized cAMP signaling pathways and significantly increased ROS production [85]. The gene discussed is AKAP1; the disease is cardiac hypertrophy.